View of Efficacy and Safety of Abrocitinib Versus Dupilumab in Patients Who Self-Identified as Having Skin of Color: A Post Hoc Analysis of JADE COMPARE

Return to Article Details Efficacy and Safety of Abrocitinib Versus Dupilumab in Patients Who Self-Identified as Having Skin of Color: A Post Hoc Analysis of JADE COMPARE Download Download PDF